| Home : November 2012 : November 08, 2012 News : ThromboGenics NV - Business Update |
ThromboGenics NV - Business Update |
November 08, 2012
LEUVEN, Belgium, November 8, 2012 /PRNewswire/ --
Regulated Information
Disclosure in accordance with the law of May 2, 2007
ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, has...
http://www.prnewswire.com/news-releases/thrombogenics-nv---business-update-177907061.html
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|